| Literature DB >> 35415662 |
Oren Hadaya1,2, Serge Yan Landau2, Hussein Muklada2, Tova Deutch-Traubmann2, Tzach Glasser3, Rawan Bransi-Nicola4, Hassan Azaizeh4, Safaa Awwad4, Fares Halahlih4, Yoav Shalev1, Nurit Argov-Argaman1.
Abstract
We assessed the potential of Pistacia lentiscus (lentisk) phenolic compounds to enhance production of milk composition in lactating goats and caprine primary mammary epithelial cells (MEC). Damascus goats were given a lentisk infusion (LI) or fresh water (FW) to drink, in a crossover design. Milk from LI vs. FW goats was 0.43% richer in fat and 30% in omega 3 fatty acids. Lentisk infusion enhanced antioxidant capacity of plasma and milk by 37% and 30% respectively, and induced transcriptional activation of antioxidant genes. To assess the direct effect of polyphenols on milk quality in terms of composition and antioxidant capacity, we used plasma collected from goats fed hay (HP) or browsed on phenolic compounds-rich pasture (primarily lentisk; PP) as a conditioning medium for primary culture of MEC. PP increased 2-fold cellular triglyceride content and 2.4-fold intracellular casein, and increased ATP production and non-mitochondrial oxygen consumption. Taken together, the results imply that lentisk phenolic compounds affect blood, MEC and milk oxidative status, which increase fat production by the mammary gland.Entities:
Keywords: Dairy goat; Lentisk; Mammary epithelial cell; Oxidative stress; Phenolic compound
Year: 2021 PMID: 35415662 PMCID: PMC8991959 DOI: 10.1016/j.fochms.2021.100034
Source DB: PubMed Journal: Food Chem (Oxf) ISSN: 2666-5662
Fig. 1HPLC chromatogram of lentisk infusion. Identified phenolic compounds according to known standards are indicated above the designated peaks as follows: 1 – gallic acid, 2 – 3,4-dihydroxybenzoic acid, 3 – catechin, 4 – syringic acid, 5 – ethyl gallate, 6 – rutin.
Feed intake and milk composition of Damascus goats drinking fresh water (FW; n = 12) or lentisk infusion (LI; n = 12).
| FW | LI | SEM | P = | |
|---|---|---|---|---|
| Chemical composition, % DM basis | ||||
| NDF | 38.5 | 39.2 | 0.35 | 0.108 |
| ADF | 24.6 | 24.1 | 0.3 | 0.105 |
| CP | 14.01 | 14.04 | 0.07 | 0.74 |
| DM intake, g day−1 | 2143 | 2160 | 49 | 0.78 |
| ME, kcal day−1 | 5.09 | 5.10 | 0.11 | 0.96 |
| Milk composition, % | ||||
| Fat | 4.19b | 4.62a | 0.14 | 0.018 |
| Protein | 3.58 | 3.65 | 0.05 | 0.35 |
| Lactose | 4.19 | 4.14 | 0.04 | 0.29 |
| Urea | 0.073 | 0.071 | 0.001 | 0.14 |
| SCC (log) | 7 | 7.05 | 0.21 | 0.84 |
| Yield (l day−1) | 1.99 | 2.09 | 0.064 | 0.204 |
| Fat yield (kg day−1) | 0.081b | 0.101a | 0.005 | 0.013 |
| Milk physical properties | ||||
| Curd firmness (volts) | 5.79 | 6.09 | 0.4 | 0.49 |
| Coagulation time (min) | 10.52 | 11.26 | 0.33 | 0.25 |
NDF = neutral detergent fiber; ADF = acid detergent fiber; DM = dry matter, according to NIRS equation developed by Landau et al. (2008); ME = metabolizable energy.
SCC = somatic cell count.
Different lowercase letters within a row indicate significant differences at P < 0.05.
Fatty acid composition (g per 100 g) in the milk of Damascus goats drinking fresh water (FW; n = 12) or lentisk infusion (LI; n = 12).
| FW | LI | SEM | P = | |
|---|---|---|---|---|
| C6:0 | 0.31 | 0.27 | 0.035 | 0.43 |
| C8:0 | 1.19 | 1.29 | 0.16 | 0.72 |
| C10:0 | 11.51 | 11.99 | 0.85 | 0.72 |
| C12:0 | 6.53 | 6.64 | 0.24 | 0.53 |
| C13:0 | 0.11 | 0.12 | 0.01 | 0.76 |
| C14:0 | 13.91 | 13.96 | 0.3 | 0.84 |
| C14:1 | 0.23 | 0.24 | 0.18 | 0.74 |
| C15:0 | 0.98 | 0.96 | 0.023 | 0.40 |
| C15:1 | 0.19 | 0.2 | 0.008 | 0.39 |
| C16:0 | 30.9 | 31.84 | 0.88 | 0.27 |
| C16:1n7 | 0.87 | 0.92 | 0.05 | 0.36 |
| C17:0 | 0.53 | 0.53 | 0.016 | 0.85 |
| C17:1 | 0.18 | 0.18 | 0.008 | 0.89 |
| C18:0 | 7.64 | 7.14 | 0.42 | 0.10 |
| C18:1n9 t | 1.84 | 1.55 | 0.16 | 0.14 |
| C18:1n9 c | 16.25 | 15.51 | 0.43 | 0.11 |
| C18:1n7 | 0.93 | 0.82 | 0.075 | 0.34 |
| C18:2n6 t | 0.67 | 0.66 | 0.076 | 0.92 |
| C18:2n6 c | 3.25 | 3.11 | 0.12 | 0.25 |
| C18:3n6 | 0.13 | 0.11 | 0.013 | 0.31 |
| C18:3n3 | 0.44B | 0.63A | 0.032 | <0.001 |
| C20:0 | 0.19a | 0.16b | 0.009 | 0.02 |
| C20:1n9 | 0.08 | 0.07 | 0.006 | 0.12 |
| C20:2n6 | 0.08 | 0.07 | 0.006 | 0.23 |
| C20:3n6 | 0.09 | 0.12 | 0.011 | 0.10 |
| C20:3n3 | 0.06 | 0.07 | 0.006 | 0.48 |
| C20:4n6 | 0.18 | 0.18 | 0.01 | 0.81 |
| C21:0 | 0.06 | 0.06 | 0.009 | 0.94 |
| C20:5n3 | 0.07 | 0.08 | 0.006 | 0.39 |
| C22:0 | 0.06 | 0.07 | 0.006 | 0.55 |
| C22:1 | 0.08 | 0.07 | 0.008 | 0.41 |
| C22:2n6 | 0.06 | 0.04 | 0.006 | 0.11 |
| C23:0 | 0.07 | 0.07 | 0.005 | 0.74 |
| C22:6n3 | 0.06 | 0.05 | 0.006 | 0.52 |
| C24:0 | 0.11 | 0.09 | 0.008 | 0.38 |
| C22:4n6 | 0.11A | 0.06B | 0.01 | 0.01 |
| C24:1 | 0.06 | 0.05 | 0.002 | 0.46 |
| SFA | 74.07 | 75.18 | 0.68 | 0.14 |
| MCFA | 34.19 | 34.97 | 1.08 | 0.60 |
| LCFA | 8.66 | 8.11 | 0.44 | 0.09 |
| MUFA | 20.7a | 19.62b | 0.52 | 0.05 |
| PUFA | 5.22 | 5.2 | 0.21 | 0.93 |
| n-6 | 4.57 | 4.35 | 0.18 | 0.33 |
| n-3 | 0.65A | 0.85B | 0.038 | <0.001 |
| n-6:n-3 | 7.22A | 5.36B | 0.25 | <0.0001 |
SFA = saturated fatty acid; MCFA = medium-chain fatty acid; LCFA = long-chain fatty acid; MUFA = monounsaturated fatty acid; PUFA = polyunsaturated fatty acid; n-6 = omega 6 fatty acid; n-3 = omega 3 fatty acid.
Different lowercase and uppercase letters within a row indicate significant differences at P < 0.05 and P < 0.01, respectively.
Fig. 2Antioxidant capacity of plasma (a) and milk (b) of goats drinking fresh water (FW; n = 12) or lentisk infusion (LI; n = 12). Values are mean ± SE. *Significant difference between groups at P < 0.05.
Fig. 3Epithelial cell production traits. Cellular lipid (a) Casein (b) and whey (c) contents caprine MEC treated with hay-based ration plasma (HP; white) or pasture-based ration plasma (PP; gray) for 24 h. n = 4 for each replicate in each treatment. *Means differ significantly at P < 0.05.
Fig. 4Respiration and metabolic activity of MEC treated with plasma collected from hay-fed goats (HP; white) or goats fed on pasture (PP; gray) as conditioning medium for 24 h. Oxygen consumption rate (OCR) was determined during basal phase respiration (a), maximal respiration after oligomycin administration (b), ATP production (c), non-mitochondrial oxygen consumption after rotenone administration (d), proton leakage (e). Significant differences between treatments at *P < 0.05; †P < 0.1.